Akero Therapeutics, Inc.
Akero Therapeutics, Inc.
AKRO
Valuace
70
Růst
0
Zdraví
75
Cena
$ 54.12
Dnes
0.00 (0.00%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
4.3B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-31%
ROA
-29%
PE
-15
PS
0
Cena 1R
21-58
⌀ Cena
48.19
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
14-11-2025
Poslední dividenda

Profil

Akero Therapeutics, Inc., společnost zabývající se kardio-metabolickou nealkoholickou steatohepatitidou (NASH), se zabývá vývojem léků určených k obnovení metabolické rovnováhy a zlepšení celkového zdraví. Hlavní kandidátskou látkou společnosti je efruxifermin (EFX), analog fibroblastového růstového faktoru 21, který chrání proti buněčnému stresu a reguluje metabolismus lipidů, sacharidů a bílkovin v těle. Provádí také klinickou studii fáze 2a, studii BALANCED, která hodnotí EFX v léčbě pacientů s NASH potvrzených biopsií. Společnost byla dříve známá jako Pippin Pharmaceuticals, Inc. a v květnu 2018 změnila svůj název na Akero Therapeutics, Inc. Společnost Akero Therapeutics, Inc. byla založena v roce 2017 a sídlí v jižním San Francisku v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
69
Založení
2019-06-20
Adresa
601 Gateway Boulevard
CEO
Andrew Cheng

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2024202320222021202020192018
Total Revenues0.000.000.000.000.000.000.000.00
Cost of Revenues0.000.0029.000.000.000.000.000.00
Gross Profit0.000.00-29.000.000.000.000.000.00
Revenue 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Revenues0.000.000.000.000.000.000.00284.000.000.00
Cost of Revenues0.000.000.000.000.001.001.002.005.0069.00
Gross Profit0.000.000.000.000.00-1.00-1.00282.00-5.00-69.00
Operating Income TTM 2024202320222021202020192018
R&D Expenses0.000.00141,798.0085,284.0081,759.0064,916.0037,046.0011,882.00
Selling General & Admin Expenses0.000.0031,072.0029,872.0019,127.0015,238.008,605.001,896.00
Depreciation & Amortization24.0018.0029.003,862.0041.0017.000.00-67,936.00
Total Operating Expenses330,016.00285,423.00172,870.00115,156.00100,886.0080,154.0045,651.0013,778.00
Operating Income-330,016.00-285,423.00-172,870.00-115,156.00-100,886.00-80,154.00-45,651.00-13,778.00
Operating Income TTM 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
R&D Expenses0.000.000.000.000.000.000.0053,392.0038,634.0027,985.00
Selling General & Admin Expenses0.000.000.000.000.000.000.008,479.007,981.007,644.00
Depreciation & Amortization4.500.004.5015.001.001.001.002.005.0069.00
Total Operating Expenses90,236.0080,873.0080,882.0078,025.0081,703.0065,740.0059,953.0061,871.0046,615.0035,629.00
Operating Income-90,236.00-80,873.00-80,882.00-78,025.00-81,703.00-65,741.00-59,954.00-61,873.00-46,615.00-35,629.00
Net Income TTM 2024202320222021202020192018
Interest Income32,052.0038,031.0024,210.000.000.000.000.000.00
Interest Expense4,618.004,668.003,099.00739.000.000.000.000.00
Other Expense37,196.0033,363.0021,111.003,123.00109.00947.001,896.00-67,936.00
IBT-292,820.00-252,060.00-151,759.00-112,033.00-100,777.00-79,207.00-43,755.00-81,714.00
Income Tax Expense0.000.000.00-3,123.00-41.00-17.000.000.00
Net Income-292,820.00-252,060.00-151,759.00-108,910.00-100,736.00-79,190.00-43,755.00-81,714.00
Net Income TTM 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Interest Income0.0011,540.0011,311.009,201.0010,244.0010,985.007,601.007,584.007,844.005,403.00
Interest Expense1,092.001,172.001,154.001,200.001,246.001,231.00991.00897.00888.00857.00
Other Expense8,670.0010,368.0010,157.008,001.008,998.009,754.006,610.006,687.006,956.004,546.00
IBT-81,566.00-70,505.00-70,725.00-70,024.00-72,705.00-55,987.00-53,344.00-55,186.00-39,659.00-31,083.00
Income Tax Expense0.000.000.000.000.000.000.00-12,527.008,732.006,260.00
Net Income-81,566.00-70,505.00-70,725.00-70,024.00-72,705.00-55,987.00-53,344.00-55,186.00-39,659.00-31,083.00
Per Share Data TTM 2024202320222021202020192018
EPS$0.00$0.00$-2.89$-2.79$-2.89$-2.52$-2.90$-3.85
EPS Diluted$0.00$0.00$-2.89$-2.79$-2.89$-2.52$-2.90$-3.85
Shares Outstanding82,008.2767,136.7752,568.0038,984.7734,827.3931,463.2515,070.7321,224.21
Diluted Shares Outstanding82,008.2767,136.7752,568.1638,984.7734,827.3931,463.2515,070.7321,224.21
Per Share Data TTM 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.99$-0.71$-0.60
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.99$-0.71$-0.60
Shares Outstanding82,008.2781,721.3978,656.6370,573.6169,442.1469,160.4859,307.7655,717.7355,613.1251,867.85
Diluted Shares Outstanding82,008.2781,721.3978,656.6370,573.6169,442.1469,160.4859,307.7655,717.7355,613.1251,867.85
Current Assets TTM 20242023202220212020201920182017
Cash And Equivalents310,355.00340,238.00234,207.00249,773.00150,483.00187,242.00136,400.0075,975.00598.00
Short Term Investments449,839.00402,840.00315,803.00101,676.0037,775.0081,145.0071,612.000.000.00
Total Cash & ST Investments760,194.00743,078.00550,010.00351,449.00188,258.00268,387.00136,400.0075,975.00598.00
Accounts Receivable0.000.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.00
Other Current Assets15,816.0027,302.009,952.003,724.005,324.002,958.001,649.001,156.0040.00
Total Current Assets776,010.00770,380.00559,962.00355,173.00193,582.00271,345.00138,049.0077,131.00638.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents176,032.00220,449.00185,922.00340,238.00316,065.00310,355.00623,854.00234,207.00269,546.00444,156.00
Short Term Investments561,794.00521,866.00500,371.00402,840.00401,182.00449,839.00279,811.00315,803.00285,186.00195,288.00
Total Cash & ST Investments737,826.00742,315.00686,293.00743,078.00717,247.00760,194.00903,665.00550,010.00554,732.00639,444.00
Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.000.00
Other Current Assets16,709.0022,285.0026,858.0027,302.0029,641.0015,816.007,615.009,952.0021,247.003,759.00
Total Current Assets754,535.00764,600.00713,151.00770,380.00746,888.00776,010.00911,280.00559,962.00575,979.00643,203.00
Long-Term Assets TTM 20242023202220212020201920182017
Net Property, Plant & Equipment900.00755.001,026.001,289.001,549.001,793.000.000.000.00
Goodwill0.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.00
Long-Term Investments88,133.0054,751.0019,283.000.000.000.000.000.000.00
Other Long-Term Assets0.000.000.00108.00417.00201.0069.0020.0020.00
Total Long-Term Assets89,033.0055,506.0020,309.001,397.001,966.001,994.0069.0020.0020.00
Total Assets865,043.00825,886.00580,271.00356,570.00195,548.00273,339.00138,118.0077,151.00658.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment552.00621.00689.00755.00835.00900.00963.001,026.001,088.001,152.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments250,490.00343,931.00442,003.0054,751.0069,824.0088,133.000.0019,283.0058,264.0019,451.00
Other Long-Term Assets0.000.000.000.000.000.000.000.000.000.00
Total Long-Term Assets251,042.00344,552.00442,692.0055,506.0070,659.0089,033.00963.0020,309.0059,352.0020,603.00
Total Assets1,005,577.001,109,152.001,155,843.00825,886.00817,547.00865,043.00912,243.00580,271.00635,331.00663,806.00
Current Liabilities TTM 20242023202220212020201920182017
Accounts Payable14,568.009,027.007,038.007,968.006,706.003,428.00947.001,373.0060.00
Short-Term Debt629.00631.00522.00325.00205.00294.000.000.000.00
Other Current Liabilities15,977.0030,096.0011,568.0010,790.0018,217.009,389.008,422.00969.00162.00
Current Liabilities31,174.0039,754.0019,128.0019,083.0025,128.0013,111.009,369.002,342.00222.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable20,399.0013,249.0010,831.009,027.0025,223.0014,568.0013,783.007,038.0011,454.0010,121.00
Short-Term Debt875.0014,657.007,309.00631.00631.00629.00640.00522.002,581.00493.00
Other Current Liabilities26,377.0032,495.0024,299.0030,096.0017,437.0015,977.0015,836.0011,568.0014,412.0010,988.00
Current Liabilities47,651.0060,401.0042,439.0039,754.0043,291.0031,174.0030,259.0019,128.0028,447.0021,602.00
Long-Term Liabilities TTM 20242023202220212020201920182017
Long-Term Debt34,959.0035,826.0025,783.0010,620.001,311.001,516.000.000.000.00
Capital Leases679.001,160.00819.001,404.001,516.001,810.000.000.000.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.00
Total Liabilities66,976.0075,774.0044,965.0030,008.0026,439.0014,627.009,392.00127,070.005,222.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt289.0022,532.0029,262.0035,826.0035,728.0035,638.0035,553.0025,783.0023,656.0025,682.00
Capital Leases0.001,528.001,096.001,160.001,236.001,308.001,390.00819.001,393.001,447.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities47,940.0083,333.0071,997.0075,774.0079,222.0066,976.0065,990.0044,965.0052,196.0047,369.00
Total Common Equity TTM 20242023202220212020201920182017
Common Stock7.007.006.005.004.004.003.000.000.00
Retained Earnings-683,427.00-826,156.00-574,096.00-422,337.00-310,304.00-209,527.00-130,320.00-86,565.00-4,564.00
Comprehensive Income-261.00948.00270.0037.00-27.00-3.00-6.000.000.00
Total Common Equity798,067.00750,112.00535,306.00326,562.00169,109.00258,712.00128,726.00-49,919.00-4,564.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock8.008.008.007.007.007.007.006.006.006.00
Retained Earnings-1,048,952.00-967,386.00-896,881.00-826,156.00-756,132.00-683,427.00-627,440.00-574,096.00-518,910.00-479,251.00
Comprehensive Income1,826.00988.001,085.00948.002,103.00-261.00-79.00270.00-506.00-251.00
Total Common Equity957,637.001,025,819.001,083,846.00750,112.00738,325.00798,067.00846,253.00535,306.00583,135.00616,437.00
Other TTM 20242023202220212020201920182017
Total Debt36,267.0036,457.0026,305.0010,945.001,516.001,810.000.000.000.00
Book Value798,067.00750,112.00535,306.00326,562.00169,109.00258,712.00128,726.00-49,919.00-4,564.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value957,637.001,025,819.001,083,846.00750,112.00738,325.00798,067.00846,253.00535,306.00583,135.00616,437.00
Cash Flow From Operating Activities TTM 2024202320222021202020192018
Net Income-204,176.00-252,060.00-151,759.00-112,033.00-100,777.00-79,207.00-43,755.00-81,714.00
Depreciation & Amortization9.0018.0029.0043.0041.0017.00-104.000.00
Stock-Based Compensation26,909.0029,698.0021,497.0023,243.0010,054.006,022.001,770.00121.00
Change Working Capital-2,593.002,998.00-6,670.00-4,459.009,727.002,085.006,462.001,061.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.00
Change In Accounts Payable4,659.002,008.00-645.00968.003,273.002,481.00-426.001,313.00
Change In Inventories0.000.000.000.000.000.000.000.00
Other Non-cash Items-5,022.00-10,761.00-8,464.00689.00203.00196.00-104.0075,907.00
Cash from Operations-190,939.000.00-145,367.00-92,517.00-79,681.00-70,804.00-35,627.00-4,625.00
Cash Flow From Operating Activities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Income-81,566.00-70,505.00-70,725.00-70,024.00-72,705.00-55,987.00-53,344.00-55,186.00-39,659.00-31,083.00
Depreciation & Amortization0.00-2,674.00-2,285.0015.00-10,105.001.001.002.005.0011.00
Stock-Based Compensation9,261.009,055.008,784.007,176.007,468.007,656.007,398.006,116.005,739.004,798.00
Change Working Capital6,184.0015,680.00-3,606.00-1,389.00-6,191.00-6,884.0013,075.003,928.00-12,712.005,158.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Change In Accounts Payable7,176.002,392.001,811.00-16,110.0010,569.001,093.006,456.00-4,229.001,339.002,876.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items-1,050.00198.00168.00-2,868.0011,109.00-2,239.00-2,270.00-8,197.00175.00170.00
Cash from Operations0.000.000.000.000.000.000.00-48,627.00-49,719.00-22,389.00
Cash Flow From Investing Activities TTM 2024202320222021202020192018
Capital Expenditure0.00-999.000.000.000.00-148.000.00-5,000.00
Acquisitions0.000.000.000.000.000.000.000.00
Investments-597,794.00-516,044.00-433,123.00-101,446.00-43,561.00-115,037.00-71,513.000.00
Sales of Investment287,835.00407,335.00209,500.0037,621.0085,841.00105,424.000.000.00
Other Investing Activities56,737.090.000.000.000.000.000.000.00
Cash from Investing-310,958.000.00-223,623.00-63,825.0042,280.00-9,761.00-71,513.00-5,000.00
Cash Flow From Investing Activities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Capital Expenditure0.000.000.000.000.000.000.000.000.000.00
Acquisitions0.000.000.000.000.000.000.000.000.000.00
Investments-73,496.00-75,676.00-583,301.00-79,728.00-57,933.00-339,407.00-38,976.00-58,214.00-161,197.00-188,802.00
Sales of Investment130,277.00155,016.00101,118.0095,000.00131,000.0084,510.0096,825.0071,000.0035,500.0060,500.00
Other Investing Activities0.000.000.000.000.000.000.0012.79-125.70-128.30
Cash from Investing0.000.000.000.000.000.000.0012,786.00-125,697.00-128,302.00
Cash Flow From Financing Activities TTM 2024202320222021202020192018
Debt Repaid-10,050.000.0015,000.00-395.000.000.000.000.00
Debt Issued20,142.0010,152.0030,360.009,824.00-294.001,810.000.000.00
Issuance of Common Stock358,096.000.00335,429.00241,200.000.00202,554.0095,452.000.00
Repurchase of Common Stock-5,778,649.000.000.00280.00373.00198.0085.000.00
Dividends Paid-336,855.000.000.000.000.000.000.000.00
Other Financing Activities557.000.002,887.0014,547.00229.00355.00451.0085,007.00
Cash from Financing368,096.000.00353,316.00255,632.00602.00203,107.0095,988.0085,007.00
Cash Flow From Financing Activities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Debt Repaid0.000.000.000.000.000.000.000.000.000.00
Debt Issued-36,025.00618.00114.0098.0092.0074.0010,150.00-194.0062.00132.00
Issuance of Common Stock0.000.000.000.000.000.000.00502.00806.00335,429.00
Repurchase of Common Stock0.000.000.000.000.000.000.00-11,529,250.005,750,601.000.00
Dividends Paid0.000.000.000.000.000.000.00-336,855.000.000.00
Other Financing Activities0.000.000.000.000.000.000.00337,357.00806.001,426.00
Cash from Financing0.000.000.000.000.000.000.00502.00806.00336,855.00
Cash position TTM 2024202320222021202020192018
Net Change in Cash-133,801.00106,031.00-15,674.0099,290.00-36,799.00122,542.00-11,152.0075,382.00
Closing Cash Balance310,355.00340,238.00234,207.00249,881.00150,591.00187,390.0064,848.0076,000.00
Cash position 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Change in Cash-44,417.0034,527.00-154,316.0024,173.005,710.00-313,499.00389,647.00-35,339.00-174,610.00186,164.00
Closing Cash Balance176,032.00220,449.00185,922.00340,238.00316,065.00310,355.00623,854.00234,207.00269,546.00444,156.00
Free Cash Flow TTM 2024202320222021202020192018
Free Cash Flow-190,939.00-231,106.00-145,367.00-92,517.00-79,681.00-70,952.00-35,627.00-9,625.00
Real Free Cash Flow-217,848.00-260,804.00-166,864.00-115,760.00-89,735.00-76,974.00-37,397.00-9,746.00
Free Cash Flow 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Free Cash Flow-67,171.00-48,246.00-67,664.00-67,090.00-70,424.00-58,452.00-35,140.00-48,627.00-49,719.00-22,389.00
Real Free Cash Flow-76,432.00-57,301.00-76,448.00-74,266.00-77,892.00-66,108.00-42,538.00-54,743.00-55,458.00-27,187.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-15.3-11.6-1.4
P/S0372559.4
P/B4.74.15.2
P/FCF-15.8-12.4-1.5
Market cap$4.3$7.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0.1 %1.8 %0 %
Debt to Income-0.4 %-6.7 %0 %
Debt to Free cash flow-0.4 %-3027.1 %0 %
Interest expense percentage-1.4 %-0.5 %44.7 %
Current ratio15.8 17.6 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-30.6 %-31 %0 %
ROA-29.1 %-36.9 %0 %
CapEx to Revenue0 %0 %0 %
RaD to Revenue0 %242331.2 %0 %
ROEM0.0 322.4

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %11.4 %68.7 %
Operating margin0 %-278235.8 %35.5 %
Net margin0 %-245669.6 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %3.3 %0 %
Dividend payout percentage0 %-24 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding82.0 mil 41.4 mil
Employee count0.1 tis 0.0 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader